Atlas Trials

Chronic Hepatitis C Virus

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Hepatitis C Virus

RecordFirmDate
Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection. (NCT02950870)University of Modena and Reggio Emilia2016-12-01
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2 (NCT02945228)AbbVie2016-10-26
Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD) (NCT02806362)AbbVie2016-09-01
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (NCT02723084)AbbVie2016-04-08
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection (NCT02707952)AbbVie2016-02-22
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) (NCT02105467)Merck Sharp & Dohme LLC2014-06-05
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) (NCT01851330)Gilead Sciences2013-05-01
Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) (NCT01852604)Merck Sharp & Dohme LLC2013-03-01
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection (NCT01768286)Gilead Sciences2013-01-01
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection (NCT01740791)Gilead Sciences2012-11-06
Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects (NCT01726517)Gilead Sciences2012-10-01
SIMpill Medication Dispensing Device in the Treatment of HCV (NCT01691235)University of Chicago2012-09-01
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD) (NCT02038387)University of Roma La Sapienza2012-07-01
VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C (NCT01581138)Vertex Pharmaceuticals Incorporated2012-07-01
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis (NCT01516918)Vertex Pharmaceuticals Incorporated2012-02-01
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 (NCT01686789)King Abdulaziz Medical City2011-01-01
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease (NCT00610597)Erasme University Hospital2005-01-01

Track Chronic Hepatitis C Virus automatically

Every clearance here is in the API, with alerts when new ones post.